Share on StockTwits

SciClone Pharmaceuticals (NASDAQ:SCLN) released its earnings data on Monday. The company reported $0.20 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.10 by $0.10, Analyst Ratings.Net reports. The company had revenue of $32.50 million for the quarter, compared to the consensus estimate of $33.40 million. During the same quarter in the prior year, the company posted ($0.04) earnings per share.

Shares of SciClone Pharmaceuticals (NASDAQ:SCLN) traded up 0.60% during mid-day trading on Monday, hitting $5.04. The stock had a trading volume of 185,870 shares. SciClone Pharmaceuticals has a 1-year low of $4.24 and a 1-year high of $6.09. The stock’s 50-day moving average is $5.09 and its 200-day moving average is $4.86. The company has a market cap of $259.5 million and a P/E ratio of 25.18.

SciClone Pharmaceuticals, Inc (NASDAQ:SCLN) is a specialty pharmaceutical company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.